KLIFO
Rene Pedersen currently serves as Chief Financial Officer at KLIFO since March 2023, with a rich history in financial leadership roles across various organizations. Prior to KLIFO, Rene held the CFO position at DanBred from December 2021 to March 2023 and served as EVP and CFO at TFS - Clinical Contract Research Organization between February and December 2021. Rene’s career at NNE from May 2016 to February 2021 encompassed roles as CFO and CVP for Finance, Legal, and IT. A significant tenure at Novo Nordisk from July 1998 to April 2016 involved advancing through several key positions, including Head of Business Support in China, Vice President of Corporate Strategy, Vice President of Corporate Controlling & Strategic Finance, and Director of Asset Management. Rene holds an Executive MBA from CBS/SIMI and a Bachelor’s degree in Economy and Controlling from Copenhagen Business School.
This person is not in any teams
KLIFO
KLIFO is an integrated North-European drug development consultancy with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark, Sweden, Germany and The Netherlands and employs more than 150 highly skilled employees.